-+ 0.00%
-+ 0.00%
-+ 0.00%

OrbiMed Advisors acquires 597,729 Traws Pharma shares worth $998,207

PUBT·04/29/2026 01:42:35
Listen to the news
OrbiMed Advisors acquires 597,729 Traws Pharma shares worth $998,207
  • OrbiMed Advisors disclosed an increase in its stake in Traws Pharma to 1,203,250 shares through an indirect holding.
  • Filing showed purchase of 597,729 shares at USD 1.67 per share.
  • OrbiMed also reported warrant positions covering up to 2,988,645 shares, with an exercise price of USD 1.67.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Traws Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000947871-26-000481), on April 28, 2026, and is solely responsible for the information contained therein.